MARKET

BCYC

BCYC

Bicycle Therapeutics Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.40
-0.60
-6.67%
Closed 16:00 12/06 EST
OPEN
9.00
PREV CLOSE
9.00
HIGH
9.02
LOW
8.20
VOLUME
20.36K
TURNOVER
--
52 WEEK HIGH
14.91
52 WEEK LOW
6.24
MARKET CAP
36.40M
P/E (TTM)
-4.3796
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BCYC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BCYC News

  • Bicycle Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference
  • Business Wire.11/26 12:00
  • Tech Retakes Leadership Role With Chips And Cloud Names Moving Higher, I See A Pattern
  • Seeking Alpha - Article.11/18 22:38
  • U.S. IPO Week Ahead: IPO Market Cashes In On Crypto As Canaan Leads 5-IPO Week
  • Seeking Alpha - Article.11/16 18:06
  • Benzinga's Top Upgrades, Downgrades For November 14, 2019
  • Benzinga.11/14 14:56

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About BCYC

Bicycle Therapeutics PLC, formerly Bicycle Therapeutics Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing a class of medicines for diseases. The Company’s lead product candidate, BT1718, is a Bicycle Toxin Conjugate (BTC) for oncology indications. BT1718 targets tumors that express Membrane Type 1 matrix metalloprotease (MT1-MMP). The Company is also developing BT5528 and BT8009, which are BTCs targeting Ephrin type-A receptor 2 (EphA2), and Nectin-4, for oncology indications. The Company is also developing cytotoxic T-cell activators, designed to trigger an immune response to tumors.
More

Webull offers Bicycle Therapeutics PLC (ADR) (BCYC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.